NASDAQConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-10-15
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
View Living FV report and workflow4 key conditions need to be met for the investment thesis to play out.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Capital expenditures below 5% of net revenue | Capital spending stays below 5% of net revenue. | Intact | capex exceeds 5% of net revenue in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Core constant currency EPS growth of 4-6% | Core EPS rises 4-6% annually. | Intact | EPS growth falls below 4% in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 4 of last 4 quarters. Core constant currency EPS grew 5% in 2026-Q1 but slowed to 1.5% in 2026-Q3, with year-to-date growth of 2%. Management maintains guidance for 4-6% growth in fiscal 2026. The trajectory shows mixed delivery with recent deceleration but overall progress toward the target. Delivery assessment Oct 15, 2026 |
Organic revenue growth between 2% and 4% | A primary condition in PepsiCo's published investment case. The stated target is 2-4% YoY. | Intact | organic revenue growth falls below 2% in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 4 of last 4 quarters. Organic revenue grew from 2.6% in 2026-Q1 to 3.1% in 2026-Q3, with year-to-date growth of 2.7%. Management has consistently guided for 2-4% organic revenue growth in fiscal 2026. The trajectory shows delivering progress aligned with stated growth targets. Delivery assessment Oct 15, 2026 |
Return approximately $8.9 billion to shareholders | The company plans to return $8.9 billion to shareholders in 2026. | Intact | shareholder returns fall materially below $8.9 billion in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 4 of last 4 quarters. Management consistently expects total cash returns to shareholders of approximately $8.9 billion in 2026, including $7.9 billion dividends and $1.0 billion share repurchases. This priority is persistently emphasized with no contradictory financial data. Delivery assessment Oct 15, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsLatest: 6 Buy / Strong Buy · 18 Hold · 1 Sell / Strong Sell
Recent actions · Sep 16–Oct 15 · 15 recorded
0 raises · 9 cuts · 0 unchanged · 2 without a comparable prior
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment is characterized as a durable compounder with a focus on steady revenue growth. The current thesis state is intact, supported by recent financial performance that remains strong relative to its industry.
The market appears to price PEP as relatively cheap compared to its peers, with a slight expectations gap indicating that investors are not overly optimistic. The valuation reflects a justified premium, suggesting that the market is aware of some fragility in execution quality.
Management is on track to achieve its organic revenue growth and core EPS growth targets, although recent results show some deceleration. The near-term risk is moderate, with a low probability of missing expectations, but the company has a history of misses that could affect sentiment.
The thesis hinges on management's ability to maintain guidance and deliver on growth targets. Additionally, external factors like inflation trends and economic conditions, particularly the jobs report, will play a significant role in shaping future performance.
Over the next 1 to 3 years, PEP's fundamentals suggest a stable outlook, but external economic factors could introduce volatility. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.